Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378].
Veldt BJ, Brouwer JT, Adler M, Nevens F, Michielsen P, Delwaide J, Hansen BE, Schalm SW; Benelux Study Group on Treatment of Chronic Hepatitis C. Veldt BJ, et al. Among authors: delwaide j. BMC Gastroenterol. 2003 Aug 29;3:24. doi: 10.1186/1471-230X-3-24. BMC Gastroenterol. 2003. PMID: 12948399 Free PMC article. Clinical Trial.
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients.
Brouwer JT, Nevens F, Bekkering FC, Bourgeois N, Van Vlierberghe H, Weegink CJ, Lefebvre V, Van Hattum J, Henrion J, Delwaide J, Hansen BE, Schalm SW; Benelux Study Group On Treatment Of Chronic Hepatitis C. Brouwer JT, et al. Among authors: delwaide j. J Hepatol. 2004 Apr;40(4):689-95. doi: 10.1016/j.jhep.2003.12.017. J Hepatol. 2004. PMID: 15030987 Clinical Trial.
Hepatitis C infection: eligibility for antiviral therapies.
Delwaide J, El Saouda R, Gérard C, Belaïche J; Groupe Liègeois d'Etude des Virus Hépatotropes. Delwaide J, et al. Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1185-9. doi: 10.1097/00042737-200511000-00006. Eur J Gastroenterol Hepatol. 2005. PMID: 16215430 Free article.
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system.
Adler M, De Pauw F, Vereerstraeten P, Fancello A, Lerut J, Starkel P, Van Vlierberghe H, Troisi R, Donckier V, Detry O, Delwaide J, Michielsen P, Chapelle T, Pirenne J, Nevens F. Adler M, et al. Among authors: delwaide j. Liver Transpl. 2008 Apr;14(4):526-33. doi: 10.1002/lt.21399. Liver Transpl. 2008. PMID: 18383082 Free article.
IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?
Orlent H, Reynaert H, Bourgeois S, Dideberg V, Adler M, Colle I, De Maeght S, Laleman W, Michielsen P, Moreno C, Mulkay JP, Stärkel P, Delwaide J; Belgian Association for the Study of the Liver. Orlent H, et al. Among authors: delwaide j. Acta Gastroenterol Belg. 2011 Jun;74(2):317-22. Acta Gastroenterol Belg. 2011. PMID: 21861317 Free article. Review.
Response-guided telaprevir combination treatment for hepatitis C virus infection.
Sherman KE, Flamm SL, Afdhal NH, Nelson DR, Sulkowski MS, Everson GT, Fried MW, Adler M, Reesink HW, Martin M, Sankoh AJ, Adda N, Kauffman RS, George S, Wright CI, Poordad F; ILLUMINATE Study Team. Sherman KE, et al. N Engl J Med. 2011 Sep 15;365(11):1014-24. doi: 10.1056/NEJMoa1014463. N Engl J Med. 2011. PMID: 21916639 Free PMC article. Clinical Trial.
HBV infection in Belgium: results of the BASL observatory of 1,456 HBsAg carriers.
Deltenre P, Laleman W, Van Gossum M, Lenaerts A, Colle I, Michielsen P, Adler M, Delwaide J, Assene C, Reynaert H, D'Heygere F, Robaeys G, de Galocsy C, Brenard R, Langlet P, Sprengers D, Mairlot MC, Preux C, Lefçbvre V, Orlent H, Henrion J. Deltenre P, et al. Among authors: delwaide j. Acta Gastroenterol Belg. 2012 Mar;75(1):35-41. Acta Gastroenterol Belg. 2012. PMID: 22567745 Free article.
169 results